By vgreene, 19 March, 2020 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™). Gilead Sciences sponsoring 2 trials, one in pts w/ severe coronavirus dz (ClinicalTrials.gov), and one in those with moderate dz (ClinicalTrials.gov)
By vgreene, 19 March, 2020 Adaptive COVID-19 Treatment Trial. NIH multicenter RCT in hospitalized adults (ClinicalTrials.gov)
By vgreene, 19 March, 2020 Some COVID-19 pts have received IV remdesivir for compassionate use1 outside of clinical trials2